Skip to main content
. 2023 Nov 6;22:187. doi: 10.1186/s12944-023-01939-4

Table 1.

Baseline characteristics Stratified by the groups with and without AAAa

Variables Unmatched population Matched population
Normal (n = 9340) AAA (n = 219) SMD P Normal (n = 219) AAA (n = 219) SMD P
Age (years) 70.3 ± 0.1 72.6 ± 0.4 0.345 < 0.001 72.6 ± 0.5 72.6 ± 0.4 0.004 0.946
BMI (Kg/m2) 23.9 ± 0.03 23.8 ± 0.2 0.043 0.507 24.0 ± 0.2 23.8 ± 0.2 0.098 0.583
Sex (male) 63.7 (5949) 89.0 (195) 0.625 < 0.001 92.2 (202) 89.0 (195) 0.110 0.251
Smoking, % 23.7 (2216) 40.2 (88) 0.358 < 0.001 37.4 (82) 40.2 (88) 0.056 0.556
Hypertension, % 54.0 (5047) 66.7 (146) 0.260 < 0.001 66.2 (145) 66.7(146) 0.010 0.919
Diabetes mellitus, % 21.6 (2013) 18.7 (41) 0.071 0.313 15.1 (33) 18.7 (41) 0.097 0.308
Coronary artery disease, % 38.8 (3627) 56.2 (3750) 0.352 < 0.001 53.0 (116) 56.2 (123) 0.064 0.502
Peripheral artery disease, % 3.3(312) 3.7(8) 0.017 0.799 5.0 (11) 3.7 (8) 0.067 0.482
Stroke, % 5.4(503) 10.0(22) 0.175 0.003 9.6 (21) 10.0 (22) 0.015 0.872
Maximal abdominal aortic diameter (mm) 19.0 (17.0–20.5) 36.0 (32.0–47.0) 2.317 < 0.001 20.0 (18.0–21.0) 36.0 (32.0–47.0) 2.303 < 0.001
ALT (U/L) 20.0 (14.7–27.7) 18.0 (14.0–25.0) 0.060 0.003 21.0 (16.0–27.4) 18.0 (14.0–25.0) 0.214 < 0.001
AST (U/L) 22.0 (18.3–28.0) 21.0 (18.7–27.5) 0.015 0.407 22.9 (19.0–28.4) 21.0 (18.7–27.5) 0.087 0.069
UA (mmol/L) 398.0 (327.9–460.0) 422.0 (368.0–504.3) 0.332 < 0.001 402.0 (351.3–483.3) 422.0 (368.0–504.3) 0.234 0.006
CR (μmol/L) 81.0 (67.0–96.8) 94.9 (77.7–118.3) 0.328 < 0.001 89.2 (75.1–105.0) 94.9 (77.7–118.3) 0.154 0.010
BUN (mmol/L) 5.5 (4.5–6.9) 6.2 (5.2–8.2) 0.320 < 0.001 5.9 (4.6–7.3) 6.2 (5.2–8.2) 0.141 0.106
TG (mmol/L) 1.4 (1.0–1.9) 1.4 (1.0–1.7) 0.087 0.912 1.4 (1.0–1.9) 1.4 (1.0–1.7) 0.039 0.245
TC (mmol/L) 4.6 (3.8–5.4) 4.6 (3.7–5.3) 0.076 0.265 4.1 (3.5–5.2) 4.6 (3.7–5.3) 0.216 0.034
LDL- C (mmol/L) 2.8 (2.2–3.5) 2.9 (2.3–3.5) 0.060 0.250 2.6 (2.0–3.3) 2.9 (2.3–3.5) 0.293 0.002
HDL-C (mmol/L) 1.1 (1.0–1.4) 1.0 (0.9–1.2) 0.102  < 0.001 1.1 (0.9–1.3) 1.0 (0.9–1.2) 0.206 0.049
non-HDL-C (mmol/L) 3.4 (2.7–4.2) 3.6 (2.8–4.2) 0.102 0.114 3.1 (2.5–3.9) 3.6 (2.8–4.2) 0.343 0.001
non-HDL-C / HDL-C ratio 2.9 (2.2–3.8) 3.5 (2.9–4.3) 0.457  < 0.001 3.0 (2.3–3.8) 3.5 (2.9–4.3) 0.449 < 0.001
Fasting glucose (mmol/L) 5.3 (4.7–6.3) 5.2 (4.5–6.6) 0.088 0.109 5.3 (4.6–6.2) 5.2 (4.5–6.6) 0.107 0.197
HBA1C (mmol/L) 6.1 (5.7–6.3) 6.0 (5.6–6.2) 0.273  < 0.001 6.1 (5.8–6.2) 6.0 (5.6–6.2) 0.236 0.021
Medication use
 Angiotensin system inhibitors, % 47.5 (4439) 56.6 (124) 0.183 0.008 54.3 (119) 56.6 (124) 0.046 0.631
 Beta-blockers, % 42.1 (3932) 62.6 (137) 0.418 < 0.001 58.0 (127) 62.6 (137) 0.093 0.329
 Statins, % 51.0 (4762) 67.1 (147) 0.332 < 0.001 65.8 (144) 147.0 (67.1) 0.029 0.761
 Metformin, % 9.6 (895) 7.8 (17) 0.065 0.365 7.8 (17) 7.8 (17) < 0.001 1.000

Abbreviations: AAA Abdominal aortic aneurysm, BMI Body mass index, ALT Alanine aminotransferase, AST aspartate aminotransferase, UA Uric acide, Cr Creatinine, BUN Blood urea nitrogen, TG Triglyceride, TC Total cholesterol, LDL-C Low-density lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol, non-HDL-C Non-high-density lipoprotein cholesterol, non-HDL-C/HDL-C ratio Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio, HbA1c Hemoglobin A1c, SMD Standardized mean difference

aValues are given as mean + standard deviation, number (percentage), or median (quartiles 1 through 3). †P-values were derived from Mann–Whitney U-tests for continuous variables, and Chi-square tests for categorical variables